Published in Ann Oncol on April 01, 2002
Evaluation of an educational video to improve the understanding of radiotherapy side effects in head and neck cancer patients. Support Care Cancer (2013) 0.82
Information giving and receiving in hematological malignancy consultations. Psychooncology (2011) 0.81
Sharing Annotated Audio Recordings of Clinic Visits With Patients-Development of the Open Recording Automated Logging System (ORALS): Study Protocol. JMIR Res Protoc (2017) 0.75
Does dictating the letter to the GP in front of a follow-up patient improve satisfaction with the consult? A randomised controlled trial. Eur Arch Otorhinolaryngol (2009) 0.75
An STS-based map of the human genome. Science (1995) 17.72
Communicating prognosis in early breast cancer: do women understand the language used? Med J Aust (1999) 3.76
Sharing decisions in cancer care. Soc Sci Med (2001) 2.70
Communication styles in the cancer consultation: preferences for a patient-centred approach. Psychooncology (2000) 2.59
Outcome of "indeterminant" colitis following ileal pouch-anal anastomosis. Dis Colon Rectum (1989) 2.41
Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol (2001) 2.34
Promoting patient participation and shortening cancer consultations: a randomised trial. Br J Cancer (2001) 2.13
Communicating prognosis in cancer care: a systematic review of the literature. Ann Oncol (2005) 2.09
Lay constructions of decision-making in cancer. Psychooncology (2002) 2.03
The take-home message: patients prefer consultation audiotapes to summary letters. J Clin Oncol (1994) 2.03
On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol (1996) 2.03
Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials. Soc Sci Med (2004) 1.90
Physician-patient-companion communication and decision-making: a systematic review of triadic medical consultations. Patient Educ Couns (2013) 1.89
Writing to referring doctors after a new patient consultation. What is wanted and what was contained in letters from one medical oncologist? Aust N Z J Med (1995) 1.75
Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching in question-asking. Br J Cancer (1999) 1.63
Oncologists' reactions to cancer patients' verbal cues. Psychooncology (2002) 1.61
Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol (2003) 1.58
Communicating prognosis to patients with metastatic disease: what do they really want to know? Support Care Cancer (2001) 1.57
General information tapes inhibit recall of the cancer consultation. J Clin Oncol (1993) 1.47
Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol (2011) 1.36
Misunderstanding in cancer patients: why shoot the messenger? Ann Oncol (1999) 1.33
Seeking informed consent to cancer clinical trials: describing current practice. Soc Sci Med (2004) 1.31
Hearing the bad news of a cancer diagnosis: the Australian melanoma patient's perspective. Ann Oncol (2001) 1.30
A YAC-based physical map of the mouse genome. Nat Genet (1999) 1.22
Informed consent: what did the doctor say? Lancet (1999) 1.21
Focus group interviews examining attitudes to randomised trials among breast cancer patients and the general community. Aust N Z J Public Health (1998) 1.21
Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet. Ann Oncol (2002) 1.19
Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training. Psychooncology (2007) 1.18
What is important in cancer care coordination? A qualitative investigation. Eur J Cancer Care (Engl) (2011) 1.17
Women's preferences for discussion of prognosis in early breast cancer. Health Expect (2001) 1.09
Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions. Psychooncology (2009) 1.08
Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes. Br J Cancer (2004) 1.07
Women's preferences and consultants' communication of risk in consultations about familial breast cancer: impact on patient outcomes. J Med Genet (2003) 1.04
Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma. Br J Cancer (2000) 1.02
Cancer by another name: a randomized trial of the effects of euphemism and uncertainty in communicating with cancer patients. J Clin Oncol (1993) 1.02
Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Educ Couns (2001) 1.01
Tailoring communication in consultations with women from high risk breast cancer families. Br J Cancer (2002) 0.99
The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost. Support Care Cancer (1998) 0.98
The context influences doctors' support of shared decision-making in cancer care. Br J Cancer (2007) 0.97
Asking questions can help: development of a question prompt list for cancer patients seeing a surgeon. Eur J Cancer Prev (2003) 0.96
Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum (1996) 0.96
Improving the letters we write: an exploration of doctor-doctor communication in cancer care. Br J Cancer (1999) 0.96
Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists. Aust N Z J Surg (1999) 0.96
Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU. Int J Radiat Oncol Biol Phys (1997) 0.95
Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: an application of multilevel models. Qual Life Res (2000) 0.93
Age-related decline in interleukin 2 production in response to influenza vaccine. J Am Geriatr Soc (1990) 0.92
Does chemotherapy shorten the latency interval of radiation-induced sarcomas? Clin Oncol (R Coll Radiol) (2011) 0.92
An examination of the initial cancer consultation of medical and radiation oncologists using the Cancode interaction analysis system. Br J Cancer (2008) 0.91
Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer. Br J Cancer (2006) 0.90
The description of pain in psychiatric and general medical patients. J Psychosom Res (1965) 0.90
Development of a communication aid to facilitate risk communication in consultations with unaffected women from high risk breast cancer families: a pilot study. J Genet Couns (2006) 0.88
Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer. Br J Cancer (2008) 0.88
Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer. Eur J Cancer (2008) 0.88
Consumer impact of an interactive decision aid for rectal cancer patients offered adjuvant therapy. Colorectal Dis (2006) 0.87
Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: a prospective population-based study over the last year of life. Gynecol Oncol (2013) 0.87
Quantifying postdischarge unmet supportive care needs of people with colorectal cancer: a clinical audit. Colorectal Dis (2011) 0.87
Management of acquired rectourinary fistulas: outcome according to cause. Dis Colon Rectum (1998) 0.87
Audiotapes and letters to patients: the practice and views of oncologists, surgeons and general practitioners. Br J Cancer (1999) 0.86
The role of psychosocial factors in the development of breast carcinoma: Part I. The cancer prone personality. Cancer (2001) 0.86
Antimicrobial susceptibilities and clinical sources of Dialister species. Antimicrob Agents Chemother (2007) 0.85
Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: a systematic review of contemporary randomized trials. Lung Cancer (2012) 0.85
Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trial. Ann Oncol (2012) 0.84
Outcomes research: what is it and why does it matter? Intern Med J (2003) 0.83
Homologous and heterologous desensitization and synergy in pathways leading to the soybean oxidative burst. Planta (2000) 0.82
The take-home message: doctors' views on letters and tapes after a cancer consultation. Ann Oncol (1993) 0.82
Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Support Care Cancer (2012) 0.82
Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma. Br J Cancer (2010) 0.81
Meeting patients' information needs beyond the year 2000. Support Care Cancer (1997) 0.80
Delay in the clinical diagnosis of breast cancer: estimating its effect on prognosis, with particular reference to medical litigation. Breast (2002) 0.80
How can communication by oncologists enhance patients' trust? An experimental study. Ann Oncol (2014) 0.79
A case of uterine tumour resembling ovarian sex cord tumour responding to second-line, single agent anastrazole. Intern Med J (2009) 0.79
Coping with metastatic melanoma: the last year of life. Psychooncology (2000) 0.79
Cancer patients' preferences for written prognostic information provided outside the clinical context. Br J Cancer (2003) 0.79
Personality and depression: a validation study of the Depressive Experience Questionnaire. J Pers Assess (1997) 0.78
Assessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysis. Qual Life Res (2014) 0.78
Predictors of psychological distress among individuals with a strong family history of malignant melanoma. Clin Genet (2007) 0.77
Patient-doctor agreement on recall of clinical trial discussion across cultures. Ann Oncol (2012) 0.76
Ethics of clinical trials. N Engl J Med (2000) 0.75
Predictors of breast cancer in women recalled following screening. Aust N Z J Surg (1999) 0.75
Phase II study of megestrol acetate for metastatic carcinoma of the prostate. Br J Urol (1987) 0.75
Patient treatment preference in advanced breast cancer: a randomized cross-over study of doxorubicin and mitozantrone. Eur J Cancer Clin Oncol (1987) 0.75
Personality and depression: a validation study of the depressive experiences questionnaire. J Pers Assess (1997) 0.75
A comparison of the FACT-G and the Supportive Care Needs Survey (SCNS) in women with ovarian cancer: unidimensionality of constructs. Qual Life Res (2011) 0.75